MwanzoTWST • NASDAQ
add
Twist Bioscience Corp
Bei iliyotangulia
$ 31.09
Bei za siku
$ 30.58 - $ 31.79
Bei za mwaka
$ 23.30 - $ 55.33
Thamani ya kampuni katika soko
1.83B USD
Wastani wa hisa zilizouzwa
1.87M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 99.01M | 16.88% |
Matumizi ya uendeshaji wa biashara | 80.77M | 8.74% |
Mapato halisi | -27.14M | 21.69% |
Kiwango cha faida halisi | -27.41 | 33.00% |
Mapato kwa kila hisa | -0.45 | 23.73% |
EBITDA | -26.83M | 16.12% |
Asilimia ya kodi ya mapato | -0.96% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 232.43M | -15.91% |
Jumla ya mali | 641.86M | 4.48% |
Jumla ya dhima | 168.90M | 19.25% |
Jumla ya hisa | 472.96M | — |
hisa zilizosalia | 61.15M | — |
Uwiano wa bei na thamani | 3.99 | — |
Faida inayotokana na mali | -11.64% | — |
Faida inayotokana mtaji | -13.19% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -27.14M | 21.69% |
Pesa kutokana na shughuli | -11.81M | 22.89% |
Pesa kutokana na uwekezaji | -12.40M | -865.21% |
Pesa kutokana na ufadhili | 5.57M | 53.68% |
Mabadiliko halisi ya pesa taslimu | -18.48M | -43.20% |
Mtiririko huru wa pesa | -14.59M | -124.74% |
Kuhusu
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2013
Tovuti
Wafanyakazi
979
